Patents by Inventor Daria Onichtchouk

Daria Onichtchouk has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • USE OF PLEITROPHIN FOR PREVENTING AND TREATING PANCREATIC DISEASES AND/OR OBESITY AND/OR METABOLIC SYNDROME
    Publication number: 20140213510
    Abstract: The present invention discloses the protein pleitrophin secreted by the developing pancreas, and polynucleotides, which identify and encode this protein. The invention also relates to the use of these sequences in the diagnosis, study, prevention, and treatment of pancreatic diseases (e.g. diabetes), obesity, and/or metabolic syndrome.
    Type: Application
    Filed: February 22, 2013
    Publication date: July 31, 2014
    Inventors: Daria ONICHTCHOUK, Ulrike BURK
  • Use of pleitrophin for preventing and treating pancreatic diseases and/or obesity and/or metabolic syndrome
    Patent number: 8501473
    Abstract: The present invention discloses the protein pleiotrophin secreted by the developing pancreas, and polynucleotides, which identify and encode this protein. The invention also relates to the use of these sequences in the diagnosis, study, prevention, and treatment of pancreatic diseases (e.g. diabetes), obesity, and/or metabolic syndrome.
    Type: Grant
    Filed: July 15, 2004
    Date of Patent: August 6, 2013
    Assignee: Evotec International GmbH
    Inventors: Daria Onichtchouk, Ulrike Burk
  • Use of pleitrophin for preventing and treating pancreatic diseases and/or obesity and/or metabolic syndrome
    Publication number: 20100162421
    Abstract: The present invention discloses the protein pleitrophin secreted by the developing pancreas, and polynucleotides, which identify and encode this protein. The invention also relates to the use of these sequences in the diagnosis, study, prevention, and treatment of pancreatic diseases (e.g. diabetes), obesity, and/or metabolic syndrome.
    Type: Application
    Filed: July 15, 2004
    Publication date: June 24, 2010
    Inventors: Daria Onichtchouk, Burk Ulrike
  • USE OF SECRETED PROTEIN PRODUCTS FOR PREVENTING AND TREATING PANCREATIC DISEASES AND/OR OBESITY AND/OR METABOLIC SYNDROME
    Publication number: 20090298771
    Abstract: This invention relates to the use of secreted SF01-SF13 proteins, to the use of polynucleotides encoding these, and to the use of effectors/modulators thereof in the diagnosis, study, prevention, and treatment of pancreatic diseases (e.g. diabetes mellitus), obesity and/or metabolic syndrome and to the use in regeneration of tissues such as pancreatic tissues and others.
    Type: Application
    Filed: May 8, 2009
    Publication date: December 3, 2009
    Applicant: DeveloGen Aktiengesellschaft
    Inventor: Daria Onichtchouk
  • Use of a Dg147 Protein Product for Preventing and Treating Metabolic Disorders
    Publication number: 20080107639
    Abstract: The present invention discloses novel uses for energy homeostasis regulating proteins and polynucleotides encoding this in the diagnosis, study, prevention, and treatment of metabolic diseases and disorders.
    Type: Application
    Filed: January 19, 2005
    Publication date: May 8, 2008
    Applicant: DEVELOGEN AKTIENGESELLSCHAFT
    Inventor: Daria Onichtchouk
  • Use of Secreted Protein Products for Preventing and Treating Pancreatic Diseases and/or Obesity and/or Metabolic Syndrome
    Publication number: 20070248579
    Abstract: This invention relates to the use of secreted SF01-SF13 proteins, to the use of polynucleotides encoding these, and to the use of effectors/modulators thereof in the diagnosis, study, prevention, and treatment of pancreatic diseases (e.g. diabetes mellitus), obesity and/or metabolic syndrome and to the use in regeneration of tissues such as pancreatic tissues and others.
    Type: Application
    Filed: February 18, 2005
    Publication date: October 25, 2007
    Applicant: DEVELOGEN AKTEIENGESELLSCHAFT
    Inventor: Daria Onichtchouk
  • Method for preventing and treating diabetes using dg119
    Publication number: 20070110728
    Abstract: The present invention relates generally to methods for preventing and/or treating pancreatic disorders, particularly those related to diabetes, by administering a DG119-1 product or a DG119-1 agonist and/or an antagonist To a DG 119-2 product.
    Type: Application
    Filed: November 29, 2004
    Publication date: May 17, 2007
    Applicant: DEVELOGEN AKTIENGESELLSCHAFT
    Inventors: Matthias Austen, Daria Onichtchouk, Thomas Siegmund, Kristin Aduroja, Bettina Rudolph, Friedrich Harder
  • Use of secreted protein products for preventing and treating pancreatic diseases and/or obesity and/or metabolic syndrome
    Publication number: 20070107073
    Abstract: The present invention discloses proteins secreted by the developing pancreas, and polynucleotides, which identify and encode these proteins. The invention also relates to the use of these sequences in the diagnosis, study, prevention, and treatment of pancreatic diseases (e.g. diabetes), obesity, and/or metabolic syndrome.
    Type: Application
    Filed: November 19, 2004
    Publication date: May 10, 2007
    Applicant: DeveloGen Aktiengesellschaft
    Inventor: Daria Onichtchouk
  • Use of protein products for preventing and treating pancreatic diseases and/or obesity and/or metabolic syndrome
    Publication number: 20070050856
    Abstract: The present invention discloses proteins expressed by the developing pancreas, and polynucleotides, which identify and encode these proteins. The invention also relates to the use of these sequences in the diagnosis, study, prevention, and treatment of pancreatic diseases (e.g. diabetes), obesity, and/or metabolic syndrome.
    Type: Application
    Filed: July 20, 2006
    Publication date: March 1, 2007
    Inventor: Daria Onichtchouk
  • Use of saposin-related proteins for preventing and treating obesity, diabetes and/or metabolic syndrome
    Publication number: 20060275274
    Abstract: The present invention discloses Saposin-related homologous proteins regulating the energy homeostasis and the metabolism of triglycerides, and polynucleotides, which identify and encode the proteins disclosed in this invention. The invention also relates to the use of these sequences in the diagnosis, study, prevention, and treatment of metabolic diseases and disorders.
    Type: Application
    Filed: March 26, 2004
    Publication date: December 7, 2006
    Inventors: Daria Onichtchouk, Karsten Eulenberg, Tri Nguyen, Ulrike Burk
  • Use of dg153 secreted protein products for preventing and treating pancreatic disease and/or obesity and/or metabolic syndrome
    Publication number: 20060241035
    Abstract: The present invention discloses proteins secreted by the developing pancreas, and polynucleotides, which identify and encode these proteins. The invention also relates to the use of these sequences in the diagnosis, study, prevention, and treatment of pancreatic diseases (e.g. diabetes), obesity, and/or metabolic syndrome.
    Type: Application
    Filed: July 8, 2004
    Publication date: October 26, 2006
    Inventor: Daria Onichtchouk
  • Use of dg008,dg065,dg210 or dg239 secreted protein products for preventing and treating pancreatic diseases and/or obesity and/or metabolic syndrome
    Publication number: 20060234930
    Abstract: The present invention discloses proteins secreted by the developing pancreas, and polynucleotides, which identify and encode the proteins. The invention also relates to the use of these sequences in the diagnosis, study, prevention, and treatment of pancreatic diseases (e.g diabetes), obesity, and/or metabolic syndrome.
    Type: Application
    Filed: July 15, 2004
    Publication date: October 19, 2006
    Inventor: Daria Onichtchouk